Treatment escalation and rise in HbA1c following successful initial metformin therapy.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Diabetes Care

• Publication date

  2006-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/DIACARE.29.03.06.DC05-1937PMID 16505496
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Secondary Failure Rates Associated with Metformin and Sulfonylurea Therapy for Type 2 Diabetes Mellitus

  2005cited by this paper
• Metabolic memory in diabetes–focus on insulin

  2005cited by this paper
• Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.

  2005cited by this paper
• Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes.

  2005cited by this paper
• The burden of treatment failure in type 2 diabetes.

  2004cited by this paper
• Slow response to loss of glycemic control in type 2 diabetes mellitus.

  2003cited by this paper
• Oral antihyperglycemic therapy for type 2 diabetes: scientific review.

  2002cited by this paper
• Utilization of oral hypoglycemic agents in a drug-insured U.S. population.

  2001cited by this paper
• Achieving further glycemic control in type 2 diabetes mellitus.

  2000cited by this paper
• Case-control study of 10 years of comprehensive diabetes care.

  2000cited by this paper
• Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

  1999cited by this paper
• Efficacy of metformin in the treatment of NIDDM. Meta-analysis.

  1999cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

  1998cited by this paper
• Management of Dyslipidemia in Adults With Diabetes

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• The assessment of refill compliance using pharmacy records: methods, validity, and applications.

  1997cited by this paper
• Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group.

  1994cited by this paper

• Combined effect of metformin and gallic acid on inflammation, antioxidant status, endoplasmic reticulum (ER) stress and glucose metabolism in fructose-fed streptozotocin-induced diabetic rats

  2021cites this paper
• Type 2 Diabetes Mellitus

  2021cites this paper
• Effect of Metformin on C-reactive Protein in Type 2 Diabetes Mellitus Patients

  2021cites this paper
• Secondary metformin monotherapy failure in individuals with type 2 diabetes mellitus

  2021cites this paper
• Patterns of drug therapy, glycemic control, and predictors of escalation – non-escalation of treatment among diabetes outpatients at a tertiary care center

  2021cites this paper
• Primary Care Management of Patients With Type 2 Diabetes: Overcoming Inertia and Advancing Therapy With the Use of Injectables.

  2019cites this paper
• Quality of Care in Patients with Type 2 Diabetes in Iran: A 5-year retrospective study

  2019cites this paper
• A novel fast-slow model of diabetes progression: Insights into mechanisms of response to the interventions in the Diabetes Prevention Program

  2019cites this paper
• Diabetes Mellitus and Its Existing Oral Drug Therapies (ODT)

  2018cites this paper
• The hemoglobin glycation index correlates with efficacy of metformin therapy in individuals newly diagnosed with type 2 diabetes mellitus

  2017cites this paper
• Pharmacoeconomic meta-analysis of oral dual therapy options in overweight patients with uncontrolled diabetes

  2017cites this paper
• Delays in treatment intensification with oral antidiabetic drugs and risk of microvascular and macrovascular events in patients with poor glycaemic control: An individual patient simulation study

  2017cites this paper
• iGlarLixi, a titratable once-daily fixed-ratio combination of basal insulin and lixisenatide for intensifying type 2 diabetes management for patients inadequately controlled on basal insulin with or without oral agents

  2017cites this paper
• Inpatient glycemic management in internal medicine: an observational multicenter study in Nanjing, China

  2017cites this paper
• A comparison of methods for estimating the temporal change in a continuous variable: Example of HbA1c in patients with diabetes

  2017cites this paper
• A Comparison of Screening Tools for the Early Detection of Peripheral Neuropathy in Adults with and without Type 2 Diabetes

  2017cites this paper
• Predictors of HbA1c levels in patients initiating metformin

  2016cites this paper
• Reasons for non-intensification of treatment in people with type 2 diabetes receiving oral monotherapy: Outcomes from the prospective DIAttitude study.

  2016cites this paper
• The 1-hour post-load glucose level is more effective than HbA1c for screening dysglycemia

  2016cites this paper
• Prevalence of undiagnosed hyperglycaemia in patients presenting to the Department of Emergency Medicine with no known history of diabetes

  2016cites this paper
• Improvement of pancreatic islets viability in the bioartificial pancreas

  2016cites this paper
• Effect of irbesartan on blood glucose levels in a mice model of type 2 diabetes mellitus

  2016cites this paper
• Neuropathy Detection, Quality of Life Tools & Treatment for Type 2 Diabetes

  2016cites this paper
• Comparison and Evaluation of Oral Hypoglycemic Drugs Combination Therapy for Control of T2DM

  2015cites this paper
• Increased Cardiovascular Disease, Resource Use, and Costs Before the Clinical Diagnosis of Diabetes in Veterans in the Southeastern U.S.

  2015cites this paper
• Predictors of response in initial users of metformin and sulphonylurea derivatives: a systematic review

  2015cites this paper
• Hyperglycaemia in patients with no history of diabetes presenting to Internal Medicine Departments

  2015cites this paper
• Opinion and knowledge among hospital medical staff regarding diagnosis of diabetes and proper usage of a specific test tube for glucose analysis

  2014cites this paper
• Patterns and determinants of new first-line antihyperglycaemic drug use in patients with type 2 diabetes mellitus.

  2014cites this paper
• Determinants of glycaemic control in a practice setting: the role of weight loss and treatment adherence (The DELTA Study)

  2014cites this paper
• We Can Change the Natural History of Type 2 Diabetes

  2014cites this paper
• Evolving Metformin Treatment Strategies in Type-2 Diabetes: From Immediate-Release Metformin Monotherapy to Extended-Release Combination Therapy

  2014cites this paper
• Impact of time to treatment intensification on glycemic goal attainment among patients with type 2 diabetes failing metformin monotherapy.

  2014cites this paper
• Processes of care, lifestyle advice, treatment and glycaemic control amongst patients with Type 2 diabetes attending the Johan Heyns Community Health Centre in Sedibeng District

  2014cites this paper
• Personalized Management of Hyperglycemia in Type 2 Diabetes

  2013cites this paper
• Time to failure of oral therapy in children with type 2 diabetes: a single center retrospective chart review

  2012cites this paper
• Therapeutic management of orally treated type 2 diabetic patients , by French general practitioners in 2010 : the DIAttitude Study

  2012cites this paper
• Better analyze the determinants of therapeutic inertia to overcome it.

  2012cites this paper
• Initial Combination Therapy with Metformin plus Colesevelam in Drug-Naïve Hispanic Patients with Early Type 2 Diabetes

  2012cites this paper
• Efficacy and tolerability of the DPP-4 inhibitor alogliptin combined with pioglitazone, in metformin-treated patients with type 2 diabetes.

  2012cites this paper
• Initial and subsequent therapy for newly diagnosed type 2 diabetes patients treated in primary care using data from a vendor‐based electronic health record

  2012cites this paper
• Time to treatment initiation with oral antihyperglycaemic therapy in US patients with newly diagnosed type 2 diabetes

  2012cites this paper
• Therapeutic management of orally treated type 2 diabetic patients, by French general practitioners in 2010: the DIAttitude Study.

  2012cites this paper
• What have we learned about the treatment of type 2 diabetes? The evolving paradigms.

  2012cites this paper
• Safety and efficacy of saxagliptin added to thiazolidinedione over 76 weeks in patients with type 2 diabetes mellitus

  2011cites this paper
• Add-on therapies to metformin for type 2 diabetes

  2011cites this paper
• Should A1C Targets Be Individualized for All People With Diabetes?

  2011cites this paper
• Validity of the primary care diagnosis of diabetes in veterans in the southeastern United States.

  2011cites this paper
• Initial combination therapy with saxagliptin and metformin provides sustained glycaemic control and is well tolerated for up to 76 weeks

  2011cites this paper
• Long term patterns of use after initiation of oral antidiabetic drug therapy

  2011cites this paper
• Initial nonadherence, primary failure and therapeutic success of metformin monotherapy in clinical practice

  2010cites this paper
• Confronting the type 2 diabetes epidemic: the emerging role of incretin-based therapies.

  2010cites this paper
• A Review of the Response to Oral Antidiabetes Agents in Patients with Type 2 Diabetes

  2010cites this paper
• Insulin Pen Use for Type 2 Diabetes—A Clinical Perspective

  2010cites this paper
• Combination therapy for patients with Type 2 diabetes: repaglinide in combination with metformin

  2010cites this paper
• Review: Durable glycaemia — the promised land:

  2009cites this paper
• A(1c) control in a primary care setting: self-titrating an insulin analog pre-mix (INITIATEplus trial).

  2009cites this paper
• Secondary Failure of Metformin Monotherapy in Clinical Practice

  2009cites this paper
• Secondary Failure of Metformin Monotherapy Secondary Failure of Metformin Monotherapy in Clinical Practice Running Title: Secondary Failure of Metformin Monotherapy

  2009cites this paper
• Glucose challenge test screening for prediabetes and undiagnosed diabetes

  2009cites this paper
• Durable glycaemia — the promised land

  2009cites this paper
• Medici di Medicina Generale e Operatori Sanitari primi attori per la promozione e la prescrizione degli stili di vita: l'esperienza dell'ASL di Brescia

  2008cites this paper
• Weight Change and Glycemic Control After Diagnosis of Type 2 Diabetes

  2008cites this paper
• Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes

  2008cites this paper
• Combination treatment in the management of type 2 diabetes: focus on vildagliptin and metformin as a single tablet

  2008cites this paper
• Optimum management of type 2 diabetes – timely introduction, optimization and intensification of basal insulin

  2008cites this paper
• Random Plasma Glucose in Serendipitous Screening for Glucose Intolerance: Screening for Impaired Glucose Tolerance Study 2

  2008cites this paper
• Type 2 Diabetes and Concomitant Illness

  2008cites this paper
• Management of Type 2 Diabetes Mellitus with Basal-Prandial Insulin Therapy: A Case-Based Review

  2007cites this paper
• Loss of Glycemic Control in Patients with Type 2 Diabetes Mellitus Who Were Receiving Initial Metformin, Sulfonylurea, or Thiazolidinedione Monotherapy

  2007cites this paper
• Not for Sale or Commercial Distribution

  2007cites this paper
• Effects of early use of pioglitazone in combination with metformin in patients with newly diagnosed type 2 diabetes

  2007cites this paper
• Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care

  2007cites this paper
• Bibliography. Current world literature. Diabetes and the endocrine pancreas.

  2007cites this paper
• Comparison between vildagliptin and metformin to sustain reductions in HbA1c over 1 year in drug‐naïve patients with Type 2 diabetes

  2007cites this paper
• Contemporary analysis of secondary failure of successful sulfonylurea therapy.

  2007cites this paper
• Delay Of Insulin Addition To Oral Combination Therapy Despite Inadequate Glycemic Control

  2007cites this paper
• Secondary failure of glycemic control for patients adding thiazolidinedione or sulfonylurea therapy to a metformin regimen.

  2007cites this paper
• The developing role of metformin (Glucophage®) in the treatment of type 2 diabetes

  2006cites this paper
• Vascular Health and Risk Management Dovepress Linagliptin as Add-on Therapy to Insulin for Patients with Type 2 Diabetes

  year unknowncites this paper